Myriad Genetics Inc (MYGN.OQ)

MYGN.OQ on NASDAQ Stock Exchange Global Select Market

34.18USD
1 May 2015
Change (% chg)

-- (--)
Prev Close
$34.18
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
233,294
52-wk High
$42.19
52-wk Low
$31.85

MYGN.OQ

Chart for MYGN.OQ

About

Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories. These technologies include the... (more)

Overall

Beta: 0.79
Market Cap(Mil.): $2,384.60
Shares Outstanding(Mil.): 71.12
Dividend: --
Yield (%): --

Financials

  MYGN.OQ Industry Sector
P/E (TTM): 23.22 37.21 40.23
EPS (TTM): 1.44 -- --
ROI: 15.65 6.96 15.26
ROE: 16.12 11.10 16.08
Search Stocks

Myriad, Quest settle dispute over genetic cancer test

- Quest Diagnostics and Myriad Genetics have settled their patent dispute over genetic testing technology used to detect breast cancer.

09 Feb 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$75.00
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ Factual Report
$161.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks